ArticleVaccines2022

Tag-Free SARS-CoV-2 Receptor Binding Domain (RBD), but Not C-Terminal Tagged SARS-CoV-2 RBD, Induces a Rapid and Potent Neutralizing Antibody Response.

Ting-Wei Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.